Fausto Zamboni
Overview
Explore the profile of Fausto Zamboni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vitale A, Trapani S, Russo F, Miele L, Svegliati Baroni G, Marchesini G, et al.
JHEP Rep
. 2024 Sep;
6(9):101147.
PMID: 39282226
Background & Aims: International consensus has recently introduced a new definition of metabolic dysfunction-associated steatotic liver disease (MASLD). We sought to analyse epidemiological trends, prognostic features, and transplant survival benefits...
2.
Manzia T, Trapani S, Nardi A, Ricci A, Lenci I, Sensi B, et al.
Dig Liver Dis
. 2024 Sep;
57(2):408-416.
PMID: 39237429
Background: The challenge of transplant waiting-lists is to provide organs for all candidates while maintaining efficiency and equity. Aims: We investigated the probability of being transplanted or of waiting-list dropout...
3.
De Battista D, Yakymi R, Scheibe E, Sato S, Gerstein H, Markowitz T, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611048
HBV is the most common risk factor for HCC development, accounting for almost 50% of cases worldwide. Despite significant advances in immunotherapy, there is limited information on the HBV-HCC tumor...
4.
Lauterio A, Cillo U, Spada M, Trapani S, De Carlis R, Bottino G, et al.
J Hepatol
. 2023 Jul;
79(6):1459-1468.
PMID: 37516203
Background & Aims: Split liver transplant(ation) (SLT) is still considered a challenging procedure that is by no means widely accepted. We aimed to present data on 25-year trends in SLT...
5.
Rendina M, Barone M, Lillo C, Trapani S, Masiero L, Trerotoli P, et al.
Front Immunol
. 2023 Jul;
14:1203854.
PMID: 37469512
Introduction: The study of immune response to SARSCoV-2 infection in different solid organ transplant settings represents an opportunity for clarifying the interplay between SARS-CoV-2 and the immune system. In our...
6.
Manzia T, Trapani S, Nardi A, Ricci A, Lenci I, Milana M, et al.
Dig Liver Dis
. 2022 Sep;
54(12):1664-1671.
PMID: 36096992
Background: Over the last decades relevant epidemiological changes of liver diseases have occurred, together with greatly improved treatment opportunities. Aim: To investigate how the indications for elective adult liver transplantation...
7.
Pilia E, Sirigu D, Mereu R, Zamboni F, Pusceddu E
Ann Med Surg (Lond)
. 2022 Aug;
80:104345.
PMID: 35992210
No abstract available.
8.
De Battista D, Zamboni F, Gerstein H, Sato S, Markowitz T, Lack J, et al.
J Hepatocell Carcinoma
. 2021 Dec;
8:1399-1413.
PMID: 34849372
Introduction: HCC is the third leading cause of cancer-related death worldwide, with chronic viral hepatitis accounting for more than 70% of the cases. Therapeutic options are limited and ineffective. The...
9.
Farci P, Niro G, Zamboni F, Diaz G
Viruses
. 2021 Jun;
13(5).
PMID: 34064419
Hepatitis D virus (HDV) is a small, defective RNA virus that depends on hepatitis B virus (HBV) for virion assembly and transmission. It replicates within the nucleus of hepatocytes and...
10.
Nishimura N, De Battista D, McGivern D, Engle R, Tice A, Fares-Gusmao R, et al.
Proc Natl Acad Sci U S A
. 2021 Apr;
118(17).
PMID: 33888584
Older age at the time of infection with hepatitis viruses is associated with an increased risk of liver fibrosis progression. We hypothesized that the pace of fibrosis progression may reflect...